A phase II trial of perifosine as second line therapy for advanced pancreatic cancer. A study of the Princess Margaret Hospital [PMH] phase II consortium. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hedley, D
  • Moore, MJ
  • Hirte, Holger
  • Siu, L
  • Vincent, M
  • Jonker, D
  • Mwang, H
  • Nagai, J
  • Dancey, J

publication date

  • June 1, 2005